1.Updated roles of adrenergic receptors in prostate cancer.
Heng-Quan LUO ; Xiang-Xing KUANG ; Ben-Yi LI
National Journal of Andrology 2014;20(4):372-376
Adrenergic receptors are members of the G-protein coupled receptor superfamily. Recent studies revealed that these adrenergic receptors are playing an important role in the growth and metastasis of prostate cancer cells. The expression of adrenergic receptors rises significantly in prostate cancer cells and tissues. Agonists of these receptors promote the growth and mobility of prostate cancer cells, while antagonists may suppress their proliferation, trigger their apoptosis, and inhibit their metastasis. Clinically, receptor antagonists can significantly reduce the risk of prostate cancer and improve its prognosis after androgen depravation therapy. This article presents an overview on the roles of adrenergic receptors in prostate cancer.
Adrenergic Agonists
;
pharmacology
;
Adrenergic Antagonists
;
pharmacology
;
Apoptosis
;
Humans
;
Male
;
Prostatic Neoplasms
;
metabolism
;
pathology
;
Receptors, Adrenergic
;
drug effects
;
physiology
2.Advances in the study of anti-atherosclerosis drugs.
Acta Pharmaceutica Sinica 2007;42(3):231-235
Several new drug targets of anti-atherosclerosis, emerging in the recent years, such as PPAR agonists, cholesteryl ester transfer protein (CETP) inhibitors, infusion of apolipoprotein A-I (apoA-I), liver X receptor (LXR) activators and phospholipid transfer protein (PLTP) inhibitors etc were reviewed.
Apolipoprotein A-I
;
therapeutic use
;
Atherosclerosis
;
drug therapy
;
metabolism
;
Benzoates
;
chemistry
;
therapeutic use
;
Benzylamines
;
chemistry
;
therapeutic use
;
Cholesterol Ester Transfer Proteins
;
antagonists & inhibitors
;
metabolism
;
DNA-Binding Proteins
;
agonists
;
metabolism
;
Humans
;
Liver X Receptors
;
Molecular Structure
;
Orphan Nuclear Receptors
;
Oxazines
;
chemistry
;
therapeutic use
;
Peroxisome Proliferator-Activated Receptors
;
agonists
;
metabolism
;
Phenylpropionates
;
chemistry
;
therapeutic use
;
Quinolines
;
chemistry
;
therapeutic use
;
Receptors, Cytoplasmic and Nuclear
;
agonists
;
metabolism
3.Screening of pregnane X receptor activation from ginsenosides.
Yu-Guang WANG ; Hao-Sheng LIU ; Xian-Xie ZHANG ; Yong XIAO ; Bei-Bei LU ; Zeng-Chun MA ; Qian-De LIANG ; Xiang-Lin TANG ; Cheng-Rong XIAO ; Hong-Ling TAN ; Bo-Li ZHANG ; Yue GAO
Acta Pharmaceutica Sinica 2013;48(1):144-148
In order to study effects of ginseng on the metabolism of drug belong to CYP3A4 substrate, screening of pregnane X receptor activation from ginsenosides was performed by reporter assay. Based on PXR-CYP3A stable translation cell lines, 13 ginsenosides were screened for pregnane X receptor activation by reporter assays, and RIF as the positive control. The effect of ginsenosides Rg1 onCYP3A4 mRNA expression was also investigated by RT-PCR. The PXR-CYP3A stable translation cell lines had good response to RIF, and the EC50 is 2.51 micro mol x L(-1). When the condition of final concentration was 10 micromol x L(-1), ginsenoside F2 and protopanaxatriol had moderate inductive effects on PXR. Panaxotriol, Rg2, pseudoginsenoside F11, Rg1, ginsenoside and Rb3 had inhibitory effects on PXR. Ginsenoside Rf1, Rg3, Rh2 and protopanaxdiol had no obvious effects on PXR. Rg1 down-regulated CYP3A4 mRNA expression in a concentration-dependent manner. Activation of pregnane X receptor by ginsenosides may influence the metabolism of drug belong to CYP3A4 substrate, and cause ginseng-drug interactions.
Cytochrome P-450 CYP3A
;
genetics
;
metabolism
;
Drug Interactions
;
Ginsenosides
;
pharmacology
;
Hep G2 Cells
;
Humans
;
RNA, Messenger
;
metabolism
;
Receptors, Steroid
;
agonists
;
antagonists & inhibitors
;
genetics
;
Sapogenins
;
pharmacology
;
Transfection
4.Development of a functional cell-based HTS assay for the identification mGluR4 modulators.
Chinese Journal of Biotechnology 2009;25(3):457-463
To identify metabotropic glutamate receptor 4 (mGluR4) modulators by Ca2+ influx assay, we developed the functional cell-based high throughput-screening (HTS) assay. The human mGluR4 cDNA was transfected into HEK-293 stably expressing promiscuous G-protein (Ga alpha15) cells. Recombinant stable mGluR4 cell line was selected under Zeocin and validated by Ca2+ influx assay. The assay was optimized on loading time of Fluo Calcium Indicator, Dimethyl sulfoxide (DMSO) tolerance and sodium hydroxide (NaOH) tolerance using agonist (L-Glutamic acid (L-Glu)) of mGluR4. The rank order of the agonist potency for the stable human mGluR4 cell line was L-(+)-2-Amino-4-phosphonobutyric acid (L-AP4) > L-Serine-O-phosphate (L-SOP) > L-Glu, and of the antagonist potency was (RS)-alpha-Methylserine-O-phosphate (MSOP) > (RS)-alpha-Methyl-4-phosphonophenylglycine (MPPG). Z' factor value of the cell line in 96- and 384-well plate format was 0.80 and 0.65. Our data indicate a successful development of functional human mGluR4 recombinant stable cell line that was suitable for high throughput screening to identify mGluR4 agonist/antagonist.
Aminobutyrates
;
pharmacology
;
Cell Line
;
DNA, Complementary
;
genetics
;
Drug Evaluation, Preclinical
;
Humans
;
Kidney
;
cytology
;
embryology
;
Phosphoserine
;
pharmacology
;
Plasmids
;
genetics
;
Receptors, Metabotropic Glutamate
;
agonists
;
antagonists & inhibitors
;
genetics
;
Transfection
5.Inhibition of acyl-coenzyme A:cholesterol acyltransferase stimulates cholesterol efflux from macrophages and stimulates farnesoid X receptor in hepatocytes.
Sojin AN ; Young Soon JANG ; Ji Seon PARK ; Byoung Mog KWON ; Young Ki PAIK ; Tae Sook JEONG
Experimental & Molecular Medicine 2008;40(4):407-417
We investigated the mechanism of spontaneous cholesterol efflux induced by acyl-coenzyme A:cholesterol acyltransferase (ACAT) inhibition, and how an alteration of cholesterol metabolism in macrophages impacts on that in HepG2 cells. Oleic acid anilide (OAA), a known ACAT inhibitor reduced lipid storage substantially by promotion of cholesterol catabolism and repression of cholesteryl ester accumulation without further increase of cytotoxicity in acetylated low-density lipoprotein-loaded THP-1 macrophages. Analysis of expressed mRNA and protein revealed that cholesterol 7alpha-hydroxylase (CYP7A1), oxysterol 7alpha- hydroxylase (CYP7B1), and cholesterol 27-hydroxylase (CYP27) were highly induced by ACAT inhibition. The presence of a functional cytochrome P450 pathway was confirmed by quantification of the biliary cholesterol mass in cell monolayers and extracelluar medium. Notably, massively secreted biliary cholesterol from macrophages suppressed the expression of CYP7 proteins in a farnesoid X receptor (FXR)-dependent manner in HepG2 cells. The findings reported here provide new insight into mechanisms of spontaneous cholesterol efflux, and suggest that ACAT inhibition may stimulate cholesterol-catabolic (cytochrome P450) pathway in lesion-macrophages, in contrast, suppress it in hepatocyte via FXR induced by biliary cholesterol (BC).
Anilides/*pharmacology
;
Bile/metabolism
;
Cells, Cultured
;
Cholesterol/*metabolism
;
Cholesterol Esters/metabolism
;
DNA-Binding Proteins/agonists/*metabolism
;
Enzyme Inhibitors/pharmacology
;
Gene Expression Regulation, Enzymologic/drug effects
;
Hepatocytes/*drug effects/metabolism
;
Humans
;
Lipid Metabolism/drug effects/genetics
;
Macrophages/*drug effects/metabolism
;
Models, Biological
;
Oleic Acids/*pharmacology
;
Receptors, Cytoplasmic and Nuclear/agonists/*metabolism
;
Sterol O-Acyltransferase/*antagonists & inhibitors/physiology
;
Transcription Factors/agonists/*metabolism
6.A "bitter" end to asthma revealed.
Protein & Cell 2011;2(6):433-434
Adrenergic beta-2 Receptor Agonists
;
pharmacology
;
Anti-Inflammatory Agents
;
pharmacology
;
Asthma
;
drug therapy
;
physiopathology
;
Chloroquine
;
pharmacology
;
Humans
;
Myocytes, Smooth Muscle
;
cytology
;
drug effects
;
metabolism
;
Quaternary Ammonium Compounds
;
pharmacology
;
Receptors, Adrenergic, beta-2
;
metabolism
;
Receptors, G-Protein-Coupled
;
agonists
;
metabolism
;
Receptors, Interleukin-4
;
antagonists & inhibitors
;
metabolism
;
Respiratory System
;
drug effects
;
metabolism
;
physiopathology
7.Microinjection of NMDA-type glutamate receptor agonist NMDA and antagonist D-AP-5 into the central nucleus of the amygdale alters water intake rather than food intake.
Junbao YAN ; Jianqun YAN ; Jinrong LI ; Ke CHEN ; Huiling SUN ; Yuan ZHANG ; Xiaolin ZHAO ; Bo SUN ; Shiru ZHAO ; Lin SONG ; Xiaojing WEI
Journal of Southern Medical University 2012;32(5):595-600
OBJECTIVETo investigate the role of N-Methyl-D-aspartic acid (NMDA)-type glutamate receptors in the central nucleus of the amygdale (CeA) in food and water intake.
METHODSMale Sprague-Dawley rats with stainless steel cannulae implanted unilaterally into the CeA were used. The prototypic NMDA receptor agonist NMDA, or the selective NMDA receptor antagonist D(-)-2-amino-5-phosphonopentanoic acid (D-AP-5) was microinjected into the CeA of satiated and euhydrated rats.
RESULTSIntra-CeA injection of 8.50, 17.00, or 34.00 nmol NMDA did not alter food intake but significantly increased water intake 0-1 h after the injection (F(3,32)=3.191, P=0.037) independent of food intake. Without affecting the food intake, injection of 6.34, 12.70, or 25.40 nmol D-AP-5 into the CeA significantly decreased water intake 0-1 h after the injection (F(3,28)=3.118, P=0.042) independent of food intake.
CONCLUSIONNMDA receptors in the CeA may participate in the control of water intake rather than food intake.
2-Amino-5-phosphonovalerate ; pharmacology ; Amygdala ; drug effects ; Animals ; Drinking ; drug effects ; Eating ; drug effects ; Excitatory Amino Acid Agonists ; pharmacology ; Excitatory Amino Acid Antagonists ; pharmacology ; Injections, Intraventricular ; Male ; N-Methylaspartate ; pharmacology ; Rats ; Rats, Sprague-Dawley ; Receptors, N-Methyl-D-Aspartate ; agonists ; antagonists & inhibitors
8.Effects of agmatine on the electrical activity of subfornical organ neurons.
Ze-Min WANG ; Shu-Mei JI ; Hao ZHANG ; Guang-Qi SUN ; Zhi-An WANG ; Rui-Rong HE
Acta Physiologica Sinica 2004;56(4):493-497
The aim of this study was to investigate the effects of agmatine (Agm) on the electrical activity of neurons in subfornical organ (SFO) slices using extracellular recording technique. The results are as follows. (1) In response to the application of Agm (1.0 micromol/L) into the superfusate for 2 min, the discharge rate of 24/28 (85.7%) subfornical neurons was decreased significantly, while the discharge rate of 4/28 (14.3%) neurons were not affected. (2) Pretreatment with L-glutamate (0.3 mmol/L) led to a marked increase in the discharge rate of 19/24 (79.2%) subfornical neurons in an epileptiform pattern and the activity of the remaining 5/24 (20.8%) neurons was unaffected. By application of Agm (1.0 micromol/L) into the superfusate for 2 min, the epileptiform dicharge of 15/19 (78.9%) neurons was suppressed significantly, while that of the other 4 (21.1%) neurons was not inhibited. (3) In 12 neurons, perfusion of the selective L-type calcium channel agonist, Bay K-8644 (0.1 micromol/L), induced a significant increase in the discharge rate of 10/12 (83.3%) neurons, while the other 2 (16.7%) neurons showed no change. The increased discharge of 8/10 (80%) neurons was reduced by application of Agm (1.0 micromol/L) into the superfusate and that of 2/10 (20%) neurons was not affected. (4) Application of nitric oxide synthase (NOS) inhibitor N(G)-nitro-L-arginine methyl ester (L-NAME, 50 micromol/L) into the superfusate also significantly increased the discharge rate of 6/9 (66.7%) neurons, and that of 3/9 (33.3%) neurons had no response. Agm (1.0 micromol/L) applied into the superfusate reduced the increased discharge of all 6/6 (100%) neurons. These results suggest that Agm can inhibit the spontaneous discharge, and L-glutamate, Bay K-8644- or L-NAME-induced discharge of neurons in SFO. These inhibitory effects of Agm may be related to the blockade of NMDA receptors and reduction in calcium influx in SFO neurons.
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
;
pharmacology
;
Action Potentials
;
drug effects
;
Agmatine
;
pharmacology
;
Animals
;
Calcium Channel Agonists
;
pharmacology
;
Female
;
Glutamic Acid
;
pharmacology
;
Hippocampus
;
physiology
;
Male
;
Neurons
;
physiology
;
Rats
;
Rats, Sprague-Dawley
;
Receptors, Drug
;
agonists
;
Receptors, N-Methyl-D-Aspartate
;
antagonists & inhibitors
;
Subfornical Organ
;
drug effects
;
physiology
9.A novel cell model targeted on GLP-1 receptor for application to anti-diabetic candidates screening.
Acta Pharmaceutica Sinica 2009;44(3):309-313
The aim of this project is to establish a GLP-1 signaling pathway targeted cell model, for screening the new class of GLP-1 receptor agonists as anti-diabetic candidates. Firstly construct a recombined plasmid with multi-copied specific response element (RIP-CRE) regulated by GLP-1 signaling pathway and E-GFP reporter gene. Transient transfect this recombined plasmid into islet cell NIT-1, then detect the responsibility of transfected cell to GLP-1 analogue, Exendin 4. For secondly, use stable transfection and monocloning cell culture to obtain a GLP-1 signaling-specific cell line. It indicates that this cell model can response to Exendin 4, which response can be completely inhibited by GLP-1 receptor antagonist, Exendin 9-39, further showing GLP-1 receptor specific activity with a cAMP-PKA-independently mechanism. Establishment of this novel cell model can be used in high-throughput drug screening of peptides or small molecular GLP-1 analogues.
Animals
;
Cell Line
;
Cyclic AMP Response Element Modulator
;
pharmacology
;
Cyclic AMP-Dependent Protein Kinases
;
antagonists & inhibitors
;
Drug Delivery Systems
;
Drug Evaluation, Preclinical
;
Genes, Reporter
;
Glucagon-Like Peptide-1 Receptor
;
Green Fluorescent Proteins
;
metabolism
;
Hypoglycemic Agents
;
agonists
;
antagonists & inhibitors
;
metabolism
;
Islets of Langerhans
;
cytology
;
drug effects
;
metabolism
;
Isoquinolines
;
pharmacology
;
Peptide Fragments
;
pharmacology
;
Peptides
;
antagonists & inhibitors
;
pharmacology
;
Plasmids
;
Rats
;
Receptors, Glucagon
;
agonists
;
antagonists & inhibitors
;
genetics
;
metabolism
;
Recombinant Proteins
;
genetics
;
metabolism
;
Signal Transduction
;
Sulfonamides
;
pharmacology
;
Transfection
;
Venoms
;
pharmacology
10.SR144528 as Inverse Agonist of CB2 Cannabinoid Receptor.
Journal of Veterinary Science 2002;3(3):179-184
It is now well established that several G protein- coupled receptors can signal without agonist stimulation (constitutive receptors). Inverse agonists have been shown to inhibit the activity of such constitutive G protein-coupled receptor signaling. Agonist activation of the Gi/o-coupled peripheral cannabinoid receptor CB2 normally inhibits adenylyl cyclase type V and stimulates adenylyl cyclase type II. Using transfected COS cells, we show here that application of SR144528, an inverse agonist of CB2, leads to a reverse action (stimulation of adenylyl cyclase V and inhibition of adenylyl cyclase II). This inverse agonism of SR144528 is dependent on the temperature, as well as on the concentration of the cDNA of CB2 transfected. Pertussis toxin blocked the regulation of adenylyl cyclase activity by SR 144528.
Adenylate Cyclase/antagonists&inhibitors/genetics/metabolism
;
Animals
;
Binding, Competitive
;
Bornanes/metabolism/*pharmacology
;
COS Cells
;
Cannabinoids/metabolism
;
Cercopithecus aethiops
;
Isoenzymes/antagonists&inhibitors/genetics/metabolism
;
Pyrazoles/metabolism/*pharmacology
;
Rats
;
*Receptor, Cannabinoid, CB2
;
Receptors, Cannabinoid
;
Receptors, Drug/agonists/*antagonists&inhibitors/genetics/metabolism
;
Signal Transduction/drug effects/physiology
;
Transfection